Canada: Doctor calls for stop of ‘demeaning’ practice of watching women swallow Mifegymiso ‘abortion pill’

0

Doctor calls for stop of 'demeaning' practice of watching women swallow Mifegymiso 'abortion pill'
Not required in Canada, but doctors at Regina General Hospital still do it

By Stephanie Taylor, CBC News
Posted: Aug 11, 2017

Doctors should stop the "demeaning" practice of supervising a woman while she swallows the Mifegymiso abortion pill, a professor says.

Dr. Wendy Norman teaches at the University of British Columbia and chairs family planning research for the Public Health Agency of Canada and Canadian Institutes of Health Research.

She said a myth exists that physicians are required to watch a patient ingest mifepristone — one of a two-drug combination packed together as Mifegymiso, for medical abortions.

Continued: http://www.cbc.ca/news/canada/saskatchewan/mifegymiso-regina-doctors-abortion-pill-supervision-1.4243642

Read more

Canada: Universal access needed for abortion pill, advocates urge

0

Universal access needed for abortion pill, advocates urge

Laura Payton, Ottawa News Bureau Online Producer
Published Friday, July 21, 2017

OTTAWA -- An organization that advocates for women's sexual health rights has given the provincial premiers a November deadline to provide universal access to Mifegymiso, a drug used to end a pregnancy.

Action Canada for Sexual Health and Rights is challenging the provinces to offer the medication free of charge to those who want it. New Brunswick, Quebec, Ontario and Alberta have already started offering it in place of surgical abortions.

Continued at source: CTV News: http://www.ctvnews.ca/politics/universal-access-needed-for-abortion-pill-advocates-urge-1.3512176

Read more

Health Canada eases restrictions on abortion pill

0

Health Canada eases restrictions on abortion pill
Health Canada has lifted two of the restrictions it had in place for Mifegymiso, a two-drug combination known as the abortion pill, advocates say

By: Alex Abdelwahab Metro Published on Thu May 18 2017

Health Canada has relaxed some of its restrictions for Mifegymiso, commonly known as the abortion pill, according to a prominent sexual health group.

Action Canada for Sexual Health and Rights said Thursday it welcomed Health Canada’s announcement it was no longer requiring pharmacists to complete a mandatory training program before being able to dispense the drug.

Continued at source: Metro News: http://www.metronews.ca/news/ottawa/2017/05/18/health-canada-eases-restrictions-on-abortion-pill.html

Read more

Canada: Abortion pill available in less than half of all Canadian provinces three months after rollout

0

Abortion pill available in less than half of all Canadian provinces three months after rollout
Ashley Csanady | March 30, 2017

The abortion pill is available in less than half of all Canadian provinces and territories three months after it first went on sale in Canada.

Medical experts and advocates had hoped Mifegymiso — the official name of the two-medication drug also know as mifepristone or RU-486 — would help close the gaping urban-rural divide in access to abortion care services in Canada. But three months in, experts warn a strict regulatory regime could further entrench that divide and only existing abortion providers will be willing or able to distribute the pill.

Just five provinces and one territory have requested the drug since its late-January launch, according to its manufacturer: Ontario, Manitoba, Saskatchewan, Alberta, British Columbia and the Yukon.

continued: http://news.nationalpost.com/news/canada/abortion-pill-available-in-less-than-half-of-all-canadian-provinces-three-months-after-rollout

Read more

Abortion pill’s Canadian launch delayed by lack of coverage, distribution rules

0

Abortion pill's Canadian launch delayed by lack of coverage, distribution rules

Kelly Grant - HEALTH REPORTER
The Globe and Mail
Published Wednesday, Mar. 01, 2017

The Canadian launch of the abortion pill is proceeding more slowly than expected, with only five abortion clinics and a handful of big-city pharmacies across the country ordering the medication since its debut in January.

Abortion providers say confusion over distribution rules and a lack of public drug coverage are partly behind the sluggish introduction of Mifegymiso, a $300 pill combination that supporters hope will eventually make it easier for rural and small-town women to end their unwanted pregnancies.

“It’s been terribly slow,” Ellen Wiebe, the medical director of the Willow Women’s Clinic in Vancouver, said of the abortion pill’s roll-out. “We’re the big customer. That shouldn’t be. It should be all over the country.”

Continued at source: Globe & Mail: http://www.theglobeandmail.com/news/national/abortion-pills-canadian-launch-delayed-by-lack-of-coverage-distribution-rules/article34181063/

Read more

Canadian debut of abortion pill Mifegymiso delayed to January

0

by Cassandra Szklarski

TORONTO — The Canadian Press
Published Monday, Nov. 28, 2016 3:08PM EST

The much-anticipated arrival of the abortion pill Mifegymiso in Canada has been delayed until the new year.

The drug’s Canadian distributor, Celopharma Inc., says it now expects to launch “some time in January.”

Company president Paula Tenenbaum gave few details in a terse email exchange but said it was related to “a change in manufacturing site.”

Last month, Tenenbaum said Mifegymiso was on track for a November debut in Canada.

[continued at link]
Source: Globe & Mail, Canadian Press

Read more

Canada: Why is getting the abortion pill to women such a complicated thing?

0

Globe editorial, The Globe and Mail

Published Monday, Sep. 26, 2016 6:00PM EDT

Already the victims of Health Canada’s glacial bureaucracy, and of its paternalistic view of their ability to safely administer prescription drugs to themselves, Canadian women waiting to be able to use the most commonly prescribed medical abortion treatment in the world woke up to a fresh slap in the face on Monday.

It now appears that Mifegymiso will not be eligible for health-care coverage in most of the country, and that women will have to shell out $300 for the treatment when it becomes available later this fall. This is appalling. The government can and should take steps to remedy this.

This latest setback comes after Celopharma Inc., the company distributing Mifegymiso in Canada, declined to spend $72,000 on a review of the medication’s cost-effectiveness that is required before it can be covered by provincial health plans.
[continued at link]
Source: Globe & Mail

Read more

Will this new pill make abortion more accessible in Canada?

Mifegymiso can widen access to abortion care by providing a non-surgical option that doesn't have to be administered in a hospital or clinic. (Charlie Neibergall/AP Photo)

1+

Published on Aug 12, 2016

by Terri Coles
TVO.org

Ontario doctors may be able to prescribe and distribute a Health Canada-approved abortion drug by as early as this fall, but some activists and researchers say federal conditions on its use will do little to make pregnancy termination available to the many women who live far from clinics or hospitals that provide abortions.

Mifepristone, also known as RU-486, is a drug that induces a medical abortion by blocking progesterone, a hormone needed to maintain pregnancy. In Canada, where it is sold under the brand name Mifegymiso, federal regulations allow the drug to be taken up to 49 days past a woman’s last menstrual period. Unlike Plan B, which prevents the implantation of a fertilized egg and is meant to be taken within a couple days of having unprotected sex, mifepristone terminates a pregnancy. The drug can widen access to abortion care by providing a non-surgical option that doesn’t have to be administered in a hospital or clinic.

“The nature of the existing restrictions on mifepristone suggest that the motivations to regulate it go beyond considerations for the women’s health,” says Rachael Johnstone, an assistant professor of politics and gender studies at Queen’s University who specializes in Canadian abortion access. “The amount of oversight that’s required is somewhat condescending, and it’s not clear that it’s [medically] required.”

Source: TVO.org

Read more